🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 03/12/2003 | 0,3531 USD |
| 03/09/2003 | 0,3531 USD |
| 20/08/2003 | 2,7443 USD |
| 04/06/2003 | 0,3435 USD |
| 05/03/2003 | 0,3435 USD |
| 04/12/2002 | 0,3435 USD |
| 04/09/2002 | 0,3435 USD |
| 05/06/2002 | 0,3340 USD |
| 06/03/2002 | 0,3340 USD |
| 05/12/2001 | 0,3340 USD |
| 30/08/2001 | 0,3340 USD |
| 31/05/2001 | 0,3244 USD |
| 07/03/2001 | 0,3244 USD |
| 06/12/2000 | 0,3244 USD |
| 30/08/2000 | 0,3244 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 05/06/1986 | 5,13 | 5,18 | 5,10 | 5,17 | +0,91% | 1,68% | 4.634.885 |
| 04/06/1986 | 5,14 | 5,16 | 5,07 | 5,12 | +0,39% | 1,67% | 5.840.294 |
| 03/06/1986 | 5,10 | 5,12 | 4,98 | 5,10 | +1,58% | 2,60% | 7.326.778 |
| 02/06/1986 | 5,13 | 5,15 | 4,98 | 5,02 | -1,81% | 3,23% | 6.643.901 |
| 30/05/1986 | 5,21 | 5,24 | 5,09 | 5,12 | -2,65% | 2,93% | 5.385.672 |
| 29/05/1986 | 5,29 | 5,30 | 5,20 | 5,25 | -0,75% | 2,00% | 5.500.742 |
| 28/05/1986 | 5,24 | 5,31 | 5,20 | 5,29 | +2,31% | 2,28% | 7.264.526 |
| 27/05/1986 | 5,18 | 5,18 | 5,05 | 5,18 | +3,72% | 2,56% | 6.443.942 |
| 23/05/1986 | 4,94 | 4,99 | 4,93 | 4,99 | +1,01% | 1,21% | 10.069.603 |
| 22/05/1986 | 4,91 | 4,96 | 4,90 | 4,94 | +0,68% | 1,21% | 8.175.658 |
| 21/05/1986 | 4,86 | 4,94 | 4,86 | 4,91 | +0,82% | 1,77% | 7.953.062 |
| 20/05/1986 | 4,82 | 4,88 | 4,80 | 4,87 | +1,17% | 1,72% | 6.108.163 |
| 19/05/1986 | 4,83 | 4,84 | 4,80 | 4,81 | -0,34% | 0,82% | 2.806.963 |
| 16/05/1986 | 4,86 | 4,86 | 4,80 | 4,83 | -0,75% | 1,36% | 7.074.000 |
| 15/05/1986 | 4,95 | 4,95 | 4,86 | 4,86 | -2,13% | 1,74% | 6.530.717 |
| 14/05/1986 | 4,85 | 4,97 | 4,83 | 4,97 | +2,95% | 2,94% | 13.831.085 |
| 13/05/1986 | 4,79 | 4,87 | 4,74 | 4,83 | +1,75% | 2,63% | 12.472.877 |
| 12/05/1986 | 4,73 | 4,76 | 4,73 | 4,74 | -0,49% | 0,70% | 4.946.141 |
| 09/05/1986 | 4,73 | 4,77 | 4,72 | 4,77 | +0,63% | 1,12% | 6.432.624 |
| 08/05/1986 | 4,73 | 4,76 | 4,72 | 4,74 | +0,35% | 0,77% | 6.127.027 |
| 07/05/1986 | 4,69 | 4,72 | 4,67 | 4,72 | +0,28% | 1,13% | 8.711.395 |
| 06/05/1986 | 4,68 | 4,72 | 4,66 | 4,71 | +1,21% | 1,42% | 9.952.646 |
| 05/05/1986 | 4,57 | 4,67 | 4,56 | 4,65 | +2,04% | 2,25% | 6.206.256 |
| 02/05/1986 | 4,53 | 4,60 | 4,53 | 4,56 | +0,88% | 1,46% | 6.515.626 |
| 01/05/1986 | 4,58 | 4,58 | 4,51 | 4,52 | -1,73% | 1,67% | 5.795.021 |
| 30/04/1986 | 4,70 | 4,72 | 4,57 | 4,60 | -2,12% | 3,24% | 9.458.410 |
| 29/04/1986 | 4,77 | 4,77 | 4,68 | 4,70 | -0,91% | 1,88% | 4.938.595 |
| 28/04/1986 | 4,67 | 4,74 | 4,67 | 4,74 | +1,42% | 1,56% | 4.614.134 |
| 25/04/1986 | 4,70 | 4,72 | 4,60 | 4,67 | -0,63% | 2,68% | 5.674.291 |
| 24/04/1986 | 4,69 | 4,73 | 4,67 | 4,70 | +0,57% | 1,27% | 8.511.437 |